Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Latest News

New Oxford Centre for Women’s Mental Health established

The University of Oxford is set to launch a new research centre dedicated to women’s mental health, bringing together expertise from medical and biological sciences with humanities for the first time.

New Lancet Series outlines roadmap to end preventable maternal deaths from postpartum haemorrhage

Leading experts from the University of Oxford and the World Health Organization are calling on the global community to invest in affordable proven solutions and change policy to end preventable deaths from bleeding during childbirth.

Recent changes in caesarean birth rates in England

Professor Marian Knight, Director of the National Perinatal Epidemiology Unit (NPEU), appeared on BBC Breakfast this morning to discuss new NPEU research examining recent changes in caesarean birth rates in England.

Exosomes are more diverse than we previously thought: implications for disease diagnosis and management

A new opinion article published in Trends in Cell Biology explores how tiny packages released by cells, known as exosomes, could help researchers better understand disease and may one day support new approaches to diagnosis and treatment.

Oxford researchers develop wearable ultrasound patch for continuous pregnancy monitoring

New technology could help identify fetal complications earlier in high-risk pregnancies. Researchers at the University of Oxford and collaborators have helped develop a wearable ultrasound patch capable of continuously monitoring fetal wellbeing during pregnancy, offering a potential new approach to identifying complications earlier in high-risk pregnancies.

Targeted Removal of sFlt-1 in Very Preterm Preeclampsia: A Promising First-in-Human Pilot Study

A first-in-human pilot study, published in Nature Medicine, suggests that selectively removing a placenta-derived protein called soluble Fms-like tyrosine kinase 1 (sFlt-1) from the blood may be a safe and feasible way to help manage very preterm preeclampsia.

Oxford to lead Europe's largest miscarriage research centre in partnership with Tommy's

The Nuffield Department of Women's & Reproductive Health is proud to announce that it is now leading Tommy's National Centre for Miscarriage Research, alongside existing partners: the University of Birmingham, the University of Warwick, and Imperial College London.

Ovarian Cancer Awareness Day 2026 highlights the need for earlier detection and better outcomes

Today, on World Ovarian Cancer Day, we recognise the impact ovarian cancer has on women and families worldwide, and the urgent need for earlier diagnosis, improved treatment, and better survival outcomes. The day also highlights the importance of continued research to improve understanding of ovarian cancer biology, diagnosis, treatment, and patient outcomes. High-grade serous ovarian cancer is the most common subtype of ovarian cancer, with many patients diagnosed at an advanced stage. Survival outcomes remain closely linked to the stage at which the disease is diagnosed.

Phase 2 Endometriosis Study Highlights a Novel Molecular Imaging Agent as a Promising Diagnostic and Monitoring Tool

A Phase II Study, published in The Lancet Obstetrics, Gynaecology & Women's Health, highlights the potential of a new molecular imaging agent, ‘99mTc-maraciclatide’, when used alongside a non-invasive scan to diagnose and monitor the development and treatment of Endometriosis.

New model of care could prevent more than 10,000 miscarriages a year in the UK, Tommy’s report suggests

Blood pressure lowering reduces cardiovascular risk across all stages of chronic kidney disease

A major international study led by researchers at the Nuffield Dept of Women's & Reproductive Health, University of Oxford has found that lowering blood pressure reduces the risk of cardiovascular disease by approximately 9–10% for every 5 mm Hg reduction in systolic blood pressure with consistent benefits across all stages of chronic kidney disease (CKD).

New data links 104 child deaths in England to temporary accommodation

New data reveals that 104 children in England have died between April 2019 and 3rd December 2024 with temporary accommodation identified as a contributing factor to their vulnerability, ill health or death.

MSc Student Heidi Long Leads Oxford's Women's Team to Victory in the 2026 Women’s Boat Race

Congratulations to MSc student, Heidi Long and the Oxford Women’s Team on their victory in the 2026 Oxford vs Cambridge Boat Race.

Global series highlights innovations and impact in post-pregnancy contraception

A collection of seven articles in Best Practice & Research Clinical Obstetrics & Gynaecology, led by Visiting Editor Anita Makins, brings together global expertise on post-pregnancy contraception - an area critical to improving maternal and newborn health outcomes worldwide.

Early pregnancy blood fat patterns linked to delayed brain development in children

The INTERBIO-21st study has identified that a pattern of fats identified in the blood of mothers early in pregnancy is associated with reduced rates of brain growth in the baby, and developmental delays in the children once they reach 2 years of age.

Endometriosis documentary

Endometriosis affects approximately 1 in 10 women worldwide, yet diagnosis can still take up to a decade; meaning education and advocacy are more prominent than ever.

DPhil Sahana Narayan receives 40 Under 40 Public Health Catalyst Award

Congratulations to the 2025 recipients of the 40 Under 40 Public Health Catalyst Awards! Together, they represent the next generation of leaders, entrepreneurs, researchers, scientists, activists, intellectual provocateurs, authors, and directors who inspire and catalyse us all to a more just and equitable world.

MitOX 2026 - Thursday, 9 April 2026

The Nuffield Department of Women's & Reproductive Health invites you to MitOX 2026 on Thursday, 9 April 2026 in Tingewick Hall, John Radcliffe Hospital, Oxford.

INTERGROWTH-21st launches Version 2 of its Growth Standards App, expanding to fetal growth and multilingual access

The INTERGROWTH-21st Project has released Version 2 of its clinical growth standards app, significantly expanding its functionality to include fetal growth standards, enhanced data export options, and in-app multilingual capability. Building on the successful launch of Version 1, which integrated the INTERGROWTH-21st Newborn Size at Birth and Preterm Postnatal Growth Standards, Version 2 now incorporates additional tools to support clinicians across the full continuum of pregnancy and early life.

Latest National Maternity Survey finds 3 in 10 new mothers in England report common postnatal mental health problems

Our latest national maternity survey, You & Your Baby 2024, provides a picture of the mental health and maternity care experiences of women who gave birth in England in May 2024. We heard from 3,728 women from across the country - 3 in 10 were from minority ethnic groups, 3 in 10 were born outside the UK, and 2 in 10 lived in the most disadvantaged areas. By hearing from thousands of women from a wide range of backgrounds, the survey paints a clear picture of mental health around childbirth and experiences of maternity care across England.

Load More

Our Research Groups